Reassessing the Role for Lamivudine in Chronic Hepatitis B Infection: A Four-Year Cohort Analysis
The data supporting the use of antiviral agents other than lamivudine in the management of patients with hepatitis B virus (HBV) infection are based on highly selected clinical trial populations that may not be representative of typical HBV-infected populations encountered in many clinics. Despite i...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2012/936259 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832562772782612480 |
|---|---|
| author | Tahir Shaikh Curtis Cooper |
| author_facet | Tahir Shaikh Curtis Cooper |
| author_sort | Tahir Shaikh |
| collection | DOAJ |
| description | The data supporting the use of antiviral agents other than lamivudine in the management of patients with hepatitis B virus (HBV) infection are based on highly selected clinical trial populations that may not be representative of typical HBV-infected populations encountered in many clinics. Despite its limitations, however, lamivudine is relatively inexpensive and widely available and, in carefully selected patients, can still be successfully used to achieve long-term HBV suppression. This study investigated the long-term effectiveness of lamivudine in an adherent, frequently monitored, noninvestigational HBV-infected cohort. |
| format | Article |
| id | doaj-art-d84c993971b54dcd8bb3fe370b8c4576 |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2012-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-d84c993971b54dcd8bb3fe370b8c45762025-02-03T01:21:55ZengWileyCanadian Journal of Gastroenterology0835-79002012-01-0126314815010.1155/2012/936259Reassessing the Role for Lamivudine in Chronic Hepatitis B Infection: A Four-Year Cohort AnalysisTahir Shaikh0Curtis Cooper1Department of Medicine, University of Ottawa, CanadaDepartment of Medicine, University of Ottawa, CanadaThe data supporting the use of antiviral agents other than lamivudine in the management of patients with hepatitis B virus (HBV) infection are based on highly selected clinical trial populations that may not be representative of typical HBV-infected populations encountered in many clinics. Despite its limitations, however, lamivudine is relatively inexpensive and widely available and, in carefully selected patients, can still be successfully used to achieve long-term HBV suppression. This study investigated the long-term effectiveness of lamivudine in an adherent, frequently monitored, noninvestigational HBV-infected cohort.http://dx.doi.org/10.1155/2012/936259 |
| spellingShingle | Tahir Shaikh Curtis Cooper Reassessing the Role for Lamivudine in Chronic Hepatitis B Infection: A Four-Year Cohort Analysis Canadian Journal of Gastroenterology |
| title | Reassessing the Role for Lamivudine in Chronic Hepatitis B Infection: A Four-Year Cohort Analysis |
| title_full | Reassessing the Role for Lamivudine in Chronic Hepatitis B Infection: A Four-Year Cohort Analysis |
| title_fullStr | Reassessing the Role for Lamivudine in Chronic Hepatitis B Infection: A Four-Year Cohort Analysis |
| title_full_unstemmed | Reassessing the Role for Lamivudine in Chronic Hepatitis B Infection: A Four-Year Cohort Analysis |
| title_short | Reassessing the Role for Lamivudine in Chronic Hepatitis B Infection: A Four-Year Cohort Analysis |
| title_sort | reassessing the role for lamivudine in chronic hepatitis b infection a four year cohort analysis |
| url | http://dx.doi.org/10.1155/2012/936259 |
| work_keys_str_mv | AT tahirshaikh reassessingtheroleforlamivudineinchronichepatitisbinfectionafouryearcohortanalysis AT curtiscooper reassessingtheroleforlamivudineinchronichepatitisbinfectionafouryearcohortanalysis |